Cellular Origins and 3P innovation Collaborate To Accelerate Industrialisation of CGT Manufacturing
Partnership to integrate 3P innovation’s cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation
As 2024 wraps up, we’re taking a moment to celebrate an incredible year – and it’s all thanks to your support!
As we welcome 2025, we're taking a moment to celebrate an incredible year – and it’s all thanks to your support!
In May, we secured a multi-million-pound partnership with Canada-based Dalton Pharma Services (a Seikagaku Group company) to deliver an advanced robotic fill-finish cell. This deal further strengthens our position as the UK's leading supplier of aseptic fill-finish technology.
We joined forces with Cellular Origins, a TTP plc company, to supercharge the industrialisation of CGT manufacturing. By integrating our cryovial filling platform, cryoFIL™, with their robotic system, Constellation™, we’re breaking new ground in fully automated CGT production. This collaboration brings us closer to making life-saving therapies more accessible.
We showcased our innovations at nine events this year, including Phacilitate, Interphex, Achema, and CPHI! Keep an eye on where we’ll be next year here: Events | 3P Innovation
Last but not least, one of our engineers, Gemma Pollock won the runner-up spot at the ISPE UK Emerging Leaders Awards! This event highlights the incredible work of rising stars in pharmaceutical engineering – and we couldn’t be prouder!
Partnership to integrate 3P innovation’s cryoFIL cryovial filling platform within Cellular Origins’ robotic system, Constellation
Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to...
As 2024 wraps up, we’re taking a moment to celebrate an incredible year – and it’s all thanks to your support! As we welcome 2025, we're taking a...